2020 ASCO Virtual Direct™ Highlights

 

GYN
15:07

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Ovarian Cancer Update: Does Maintenance Olaparib Provide an Unprecedented OS Improvement in Relapsed, High-grade Serous or Endometrioid Disease?

FEATURING Rebecca Stone
  • 110 views
  • July 16, 2020
06:05

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Ovarian Cancer Update: Efficacy Analysis of Non-chemo Options for Platinum Sensitive Relapse

FEATURING Rebecca Stone
  • 713 views
  • July 16, 2020
  • 1
09:00

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Improvements in Endometrial Cancer: Single Agent IO in “Non-biomarker” Selected Patients, Cabozantinib + Nivolumab in Advanced Recurrent Metastatic Disease, anti-HER-2 in Advanced or Recurrent Uterine Serous Carcinoma

FEATURING Rebecca Stone
  • 50 views
  • July 16, 2020
04:31

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Cervical Cancer Update: What Is the Long-term Oncological Safety of Sentinel Lymph Node Biopsy in Early-stage Cervical Cancer?

FEATURING Rebecca Stone
  • 24 views
  • July 16, 2020